Send Enquiry

CURE
Tablets
Packaging and packing Type
Blister | 10x15
MRP :
₹179
PTR :
₹136.38
PTS :
₹122.74
Prescription medicine Read More
Composition
Send Enquiry
Available on PCD franchise with monopoly rights: Cardiac and diabetic PCD franchise
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Glivib M is a tablet from Vibcare Pharma. Each tablet carries Metformin 500 mg together with Gliclazide 80 mg. It belongs to the anti-diabetic class of medicines, and it is packed as 10x15 (Blister).
Two ingredients act in different ways to bring down blood sugar. Metformin reduces the amount of sugar the liver makes and improves the body's response to insulin. Gliclazide, a sulfonylurea, stimulates the pancreas to release insulin; this can cause low blood sugar. Together, they help lower blood sugar.
Glivib M is used in adults with type 2 diabetes mellitus, as an addition to diet and exercise, when sugar control is not achieved with one medicine alone.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
For distributors and medical representatives
Glivib M 80/500 Tablet is part of Vibcare Pharma's cardiac and diabetic range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.
Cardiac and diabetic PCD franchisePCD pharma franchise with Vibcare
Glivib M tablets contain Metformin 500 mg and Gliclazide 80 mg and are used to improve blood sugar control in type 2 diabetes. Main uses: type 2 diabetes mellitus in adults, as an addition to diet and exercise to improve blood sugar control; for patients whose sugar is not controlled by metformin or gliclazide alone.
Common side effects of Glivib M 80/500 Tablet include nausea or vomiting; diarrhoea; stomach pain or loss of appetite; metallic taste in the mouth; low blood sugar (sweating, shakiness, dizziness, hunger); headache. Get medical help at once if you notice lactic acidosis (rare): unusual muscle pain, trouble breathing, feeling very sleepy, stomach pain with vomiting; severe low blood sugar needing help from another person; allergic skin reactions such as rash or itching.
Each Glivib M 80/500 tablet contains Metformin 500 mg + Gliclazide 80 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Glivib M 80/500 Tablet only as your doctor advises.
The MRP of Glivib M 80/500 Tablet is ₹179 for a pack of 10x15 (Blister). For chemists and distributors, the PTR is ₹136.38 and the PTS is ₹122.74.
Each Glivib M 80/500 tablet contains Metformin 500 mg + Gliclazide 80 mg. It comes in a pack of 10x15 (Blister).
Two ingredients act in different ways to bring down blood sugar. Metformin reduces the amount of sugar the liver makes and improves the body's response to insulin. Gliclazide, a sulfonylurea, stimulates the pancreas to release insulin; this can cause low blood sugar. Together, they help lower blood sugar.
Must not be used in type 1 diabetes mellitus. Must not be used in severe kidney impairment or in metabolic acidosis, including diabetic ketoacidosis. Must not be used by anyone with a serious allergy to metformin, gliclazide or other sulfonylureas. Check with a doctor first if you have kidney or liver disease, are over 65 years of age, drink alcohol heavily, are pregnant or breastfeeding, or are fasting or eating irregularly. Check with a doctor first before any surgery or scan with contrast dye, as the medicine may need to be paused.
Glivib M 80/500 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner